Increased GABA concentrations in type 2 diabetes mellitus are related to lower cognitive functioning

AbstractType 2 diabetes mellitus is associated with accelerated cognitive decline. The underlying pathophysiological mechanisms still remain to be elucidated although it is known that insulin signaling modulates neurotransmitter activity, including inhibitory &ggr;-aminobutyric acid (GABA) and excitatory glutamate (Glu) receptors. Therefore, we examined whether levels of GABA and Glu are related to diabetes status and cognitive performance.Forty-one participants with type 2 diabetes and 39 participants without type 2 diabetes underwent detailed cognitive assessments and 3-Tesla proton MR spectroscopy. The associations of neurotransmitters with type 2 diabetes and cognitive performance were examined using multivariate regression analyses controlling for age, sex, education, BMI, and percentage gray/white matter ratio in spectroscopic voxel.Analysis revealed higher GABA+ levels in participants with type 2 diabetes, in participants with higher fasting blood glucose levels and in participants with higher HbA1c levels, and higher GABA+ levels in participants with both high HbA1c levels and less cognitive performance.To conclude, participants with type 2 diabetes have alterations in the GABAergic neurotransmitter system, which are related to lower cognitive functioning, and hint at the involvement of an underlying metabolic mechanism.

[1]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[2]  M. Targosz-Gajniak,et al.  Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia , 2013, Journal of the Neurological Sciences.

[3]  A A Maudsley,et al.  Associations of age, gender and body mass with 1H MR‐observed brain metabolites and tissue distributions , 2012, NMR in biomedicine.

[4]  Rodica Pop-Busui,et al.  Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. , 2012, Academic radiology.

[5]  Y. D. Reijmer,et al.  A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus , 2009, Diabetologia.

[6]  J. Luchsinger.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. , 2008, European journal of pharmacology.

[7]  J. Clarke,et al.  Medicine , 1907, Bristol medico-chirurgical journal.

[8]  R. Edden,et al.  Gannet: A batch‐processing tool for the quantitative analysis of gamma‐aminobutyric acid–edited MR spectroscopy spectra , 2014, Journal of magnetic resonance imaging : JMRI.

[9]  Senthil Kumaran,et al.  Measurement of Brain Metabolites in Patients with type 2 Diabetes and Major Depression Using Proton Magnetic Resonance Spectroscopy , 2007, Neuropsychopharmacology.

[10]  A. Alkan,et al.  Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. , 2008, Journal of diabetes and its complications.

[11]  K O Lim,et al.  In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. , 1999, Archives of general psychiatry.

[12]  Geert Jan Biessels,et al.  Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. , 2008, European journal of pharmacology.

[13]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[14]  Ashley D Harris,et al.  Tissue correction for GABA‐edited MRS: Considerations of voxel composition, tissue segmentation, and tissue relaxations , 2015, Journal of magnetic resonance imaging : JMRI.

[15]  C. Kahn,et al.  Insulin Action in Brain Regulates Systemic Metabolism and Brain Function , 2014, Diabetes.

[16]  W. Mali,et al.  MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance , 2010, Neuroradiology.

[17]  B J Soher,et al.  Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference , 1993, NMR in biomedicine.

[18]  E. McNay,et al.  Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes , 2011, Neurobiology of Learning and Memory.

[19]  A. Schousboe,et al.  Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model , 2012, Neurochemistry International.

[20]  C. Ackerley,et al.  Recruitment of functional GABAA receptors to postsynaptic domains by insulin , 1997, Nature.

[21]  L. Reagan.  Diabetes as a chronic metabolic stressor: Causes, consequences and clinical complications , 2012, Experimental Neurology.

[22]  M. V. van Boxtel,et al.  Effects of Type 2 Diabetes on 12-Year Cognitive Change , 2013, Diabetes Care.

[23]  C. Andrade.  Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications , 2010, Mens Sana Monographs.

[24]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[25]  Amy J. Ross,et al.  Magnetic resonance spectroscopy in cognitive research , 2004, Brain Research Reviews.

[26]  P. Renshaw,et al.  Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[27]  D. Alkon,et al.  Insulin and the insulin receptor in experimental models of learning and memory. , 2004, European journal of pharmacology.

[28]  P. Dagnelie,et al.  The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities , 2014, European Journal of Epidemiology.

[29]  S. Ferreira,et al.  How does brain insulin resistance develop in Alzheimer's disease? , 2014, Alzheimer's & Dementia.

[30]  O Nalcioglu,et al.  Homonuclear J‐refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopy , 1995, Magnetic resonance in medicine.

[31]  M. Górska,et al.  The Effect of Insulin Infusion on the Metabolites in Cerebral Tissues Assessed With Proton Magnetic Resonance Spectroscopy in Young Healthy Subjects With High and Low Insulin Sensitivity , 2013, Diabetes Care.

[32]  Claude Messier,et al.  The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function , 2004, Journal of clinical and experimental neuropsychology.

[33]  Walter H Backes,et al.  On the Interplay of Microvasculature, Parenchyma, and Memory in Type 2 Diabetes , 2015, Diabetes Care.